EUROPEAN MEDICAL S
3.77931
EUR
(+0.99%)
04/07/2025 - 11:42
Open 15 min delayed data - Euronext Bruxelles
| Open: | 3.73901 |
| Change: | +0.03696 |
| Volume: | 146,430 |
| Low: | 3.73679 |
| High: | 3.81954 |
| High / Low range: | 0.08275 |
| Type: | Stocks |
| Ticker: | ALEMS |
| ISIN: | BE0974497290 |
EUROPEAN MEDICAL S news, videos and press releases - Page 2
For more news please use our advanced search feature.
EUROPEAN MEDICAL S - More news...
EUROPEAN MEDICAL S - More news...
- 05/23/2023 - 17:30 DMS IMAGING : End of the ongoing procedure with Thierry Legon and reinstatement of the judicial reorganization plan homologated on February 9, 2021.
- 04/20/2023 - 16:10 Record quarterly revenue: EUR 10.1 million in the 1st quarter of 2023, organic growth +16% - Confirmation of 2023 targets and perspectives
- 01/20/2023 - 06:35 2022 revenue: EUR 35.3 m - 2023 targets and perspectives
- 01/12/2023 - 06:35 Fujifilm Healthcare Italy wins tender for 96 X-ray tables, designed and produced by DMS Imaging
- 10/03/2022 - 15:00 2022 bi-annual results
- 02/28/2022 - 17:40 DMS Imaging: Information on the Total Number of Voting Rights and Shares
- 02/28/2022 - 17:27 DMS Imaging: Publication Regarding a Transparency Notification
- 01/27/2021 - 11:45 SQZ Biotechnologies Presents Preclinical Data for their SQZ Tolerizing Antigen Carrier Platform in Antigen-Specific Immune Tolerance (ASIT) Digital Summit Invited Talk
- 09/30/2020 - 16:00 ASIT biotech Presents Its 2020 Half Year Results and Provides a Business Update Until End 2020
- 02/12/2020 - 06:00 ASIT biotech Obtains the Benefit of the Judicial Reorganization by Collective Agreement
- 01/20/2020 - 11:49 ASIT biotech Reintroduces an Application for Judicial Reorganization and Modifies the Composition of Its Board of Directors
- 12/20/2019 - 09:30 ASIT biotech Discloses Next Steps Following gp-ASIT+TM Phase III Results
- 10/17/2019 - 05:00 ASIT biotech mode of action study of gp-ASIT+™ for grass pollen allergy published in The Journal of Allergy and Clinical Immunology (JACI)1
- 10/07/2019 - 05:00 ASIT biotech receives GMP certification for its manufacturing site in Liège, Belgium
- 10/03/2019 - 15:45 ASIT biotech: Information on the Total Number of Voting Rights and Shares
- 09/26/2019 - 05:00 ASIT biotech firmly on course for readout of Phase III clinical study in grass pollen allergy
-
07/23/2019 - 14:13
Executive interview – ASIT Biotech
-
07/16/2018 - 09:14
Executive interview - ASIT Biotech
